The Role of Pneumococcal Pneumonia among CommunityAcquired Pneumonia in Adult Turkish Population: TurkCAP Study

Basit Öğe Kaydı
dc.authorwosidgok, Sebnem eren / E-8287-2016
dc.authorwosidaksoy, firdevs / A-7184-2016
dc.contributor.authorSenol, Esin
dc.contributor.authorCilli, Aykut
dc.contributor.authorGunen, Hakan
dc.contributor.authorSener, Alper
dc.contributor.authorDumlu, Ridvan
dc.contributor.authorOdemis, Ayse
dc.contributor.authorHasanoglu, Canan
dc.date.accessioned2021-11-01T15:06:17Z
dc.date.available2021-11-01T15:06:17Z
dc.date.issued2021
dc.department[Belirlenecek]
dc.description.abstractOBJECTIVE: To evaluate the rate of pneumococcal pneumonia (PP) among patients with community-acquired pneumonia (CAP) in Turkey and to investigate and compare features of PP and non-PP CAP patients. MATERIAL AND METHODS: This multicenter, non-interventional, prospective, observational study included adult CAP patients (age = 18 years). Diagnosis of PP was based on the presence of at least 1 positive laboratory test result for Streptococcus pneumoniae (blood culture or sputum culture or urinary antigen test [UAT]) in patients with radiographic findings of pneumonia. RESULTS: Four hundred sixty-five patients were diagnosed with CAP, of whom 59 (12.7%) had PP. The most common comorbidity was chronic obstructive pulmonary disease (30.1%). The mean age, smoking history, presence of chronic neurological disease, and CURB-65 score were significantly higher in PP patients, when compared to non-PP patients. In PP patients, 84.8% were diagnosed based ony on the UAT. The overall rate of PP patients among CAP was calculated as 22.8% considering the UAT sensitivity ratio of 63% (95% confidence interval: 45-81). The rate of intensive care treatment was higher in PP patients (P =.007). While no PP patients were vaccinated for pneumococcus, 3.8% of the non-PP patients were vaccinated (P =.235). Antibiotic use in the preceding 48 hours was higher in the non-PP group than in the PP group (31.8% vs. 11.1%, P =.002). The CURB-65 score and the rate of patients requiring inpatient treatment according to this score were higher in the PP group. CONCLUSION: The facts that PP patients were older and required intensive care treatment more frequently as compared to non-PP patients underline the burden of PP.
dc.description.sponsorshipPfizer Pharmaceuticals, TurkeyPfizeren_US
dc.description.sponsorshipThis work was supported by Pfizer Pharmaceuticals, Turkey.en_US
dc.identifier.doi10.5152/TurkThoracJ.2021.20223
dc.identifier.endpage345en_US
dc.identifier.issn2149-2530
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85109329980
dc.identifier.scopusqualityN/A
dc.identifier.startpage339en_US
dc.identifier.urihttps://doi.org/10.5152/TurkThoracJ.2021.20223
dc.identifier.urihttps://hdl.handle.net/11491/7534
dc.identifier.volume22en_US
dc.identifier.wosWOS:000672640800011
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.institutionauthor[Belirlenecek]
dc.language.isoen
dc.publisherAves
dc.relation.ispartofTurkish Thoracic Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectStreptococcus pneumoniaeen_US
dc.subjectcommunity-acquired pneumoniaen_US
dc.subjectadulten_US
dc.titleThe Role of Pneumococcal Pneumonia among CommunityAcquired Pneumonia in Adult Turkish Population: TurkCAP Study
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu